Non-Specific Interstitial Pneumonia (NSIP): A Patient Guide
At a Glance
NSIP is a pattern of inflammation and scarring in the lungs, not a single disease with one cause. Doctors use imaging, biopsy when needed, and evaluation for autoimmune conditions to guide individualized treatment and long-term monitoring.
Non-Specific Interstitial Pneumonia (NSIP) is a rare and complex lung condition characterized by a specific pattern of inflammation and scarring within the deep tissues of the lungs. Unlike many diseases that are defined by a single cause, NSIP is often a “pattern of injury” that the lungs develop in response to various triggers, such as an underlying autoimmune disorder, certain medications, or environmental exposures [1]. Because this pattern can look like several other types of lung disease, reaching a definitive diagnosis often benefits from a multidisciplinary approach, where lung specialists, radiologists, and pathologists work together to review the evidence [2].
What NSIP Does Not Mean
Having an “NSIP pattern” on a scan or biopsy does not automatically determine your prognosis, severity, or exact treatment. A working diagnosis can evolve as new information—such as the emergence of an autoimmune disease—becomes available.
Understanding your specific type of NSIP is an important step in managing the condition, as it typically presents in two broad forms: cellular and fibrotic. The cellular form is dominated by inflammation and often responds to immunosuppressive treatment, while the fibrotic form involves more permanent scarring [3]. However, these are broad concepts, and many patients have “mixed” disease with overlapping features. Distinguishing between these forms—and ruling out look-alike conditions like Idiopathic Pulmonary Fibrosis (IPF)—is critical because the treatments can vary significantly [4]. Identifying whether your NSIP is “secondary” to another condition, like lupus or rheumatoid arthritis, is also a priority, as treating the primary cause is often the best way to protect your lungs [5].
Living with NSIP is a long-term journey that involves balancing medical treatment with daily wellness. Treatment plans are highly individualized, often focusing on “quieting” an overactive immune system or, in selected progressive fibrosing cases, using medications that specifically target scar tissue formation [6]. Alongside these medications, your care will likely include regular breathing tests to track your progress and pulmonary rehabilitation to help you stay active and strong [7]. While a diagnosis of a rare lung disease comes with uncertainty, consistent monitoring and a personalized management plan can help you navigate the challenges of the condition.
In this guide
6 chapters
Validation & Orientation: Understanding NSIP
Learn what a non-specific interstitial pneumonia (NSIP) diagnosis means, why it takes time, and how CT scans, autoimmune testing, and expert review help confirm it.
Symptoms & Warning Signs of NSIP
Learn NSIP symptoms, how to recognize gradual progression, infection, or an acute flare, and which breathing changes or oxygen drops need urgent medical care.
Biology, Etiology, and Subtypes of NSIP
Learn how NSIP affects lung tissue, including cellular and fibrotic subtypes, autoimmune causes, medication triggers, hypersensitivity pneumonitis overlap.
The Diagnostic Process and Your Medical Reports
Learn how non-specific interstitial pneumonia (NSIP) is diagnosed using HRCT, report terms, biopsy findings, and review for look-alikes such as UIP and HP.
Treatment Options and Shared Decisions
Learn how NSIP treatment choices work, including prednisone, mycophenolate, nintedanib, infection prevention, side-effect monitoring, and ongoing follow-up care.
Long-Term Monitoring and Daily Management
Learn how to monitor non-specific interstitial pneumonia, track FVC and DLCO, recognize pulmonary hypertension signs, and use exercise and oxygen safely.
Common questions in this guide
What is NSIP, and what can cause it?
How are cellular and fibrotic NSIP different?
How do doctors confirm an NSIP diagnosis?
What treatments may be used for NSIP?
How is NSIP monitored over time?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my tests, do I have the cellular or fibrotic form of NSIP, and what does that mean for my treatment path?
- 2.How certain is the multidisciplinary team about this diagnosis compared to other interstitial lung diseases?
- 3.Are we continuing to look for an underlying cause, such as an autoimmune or connective tissue disease?
- 4.What are the long-term goals for my lung function and physical activity?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (7)
- 1
Idiopathic non-specific interstitial pneumonia.
Belloli EA, Beckford R, Hadley R, Flaherty KR
Respirology (Carlton, Vic.) 2016; (21(2)):259-68 doi:10.1111/resp.12674.
PMID: 26564810 - 2
Imaging Features of Idiopathic Interstitial Lung Diseases.
Batra K, Adams TN
Journal of thoracic imaging 2023; (38(Suppl 1)):S19-S29 doi:10.1097/RTI.0000000000000728.
PMID: 37505195 - 3
Nonspecific Interstitial Pneumonia: What Is the Optimal Approach to Management?
Tomassetti S, Ryu JH, Piciucchi S, et al.
Seminars in respiratory and critical care medicine 2016; (37(3)):378-94 doi:10.1055/s-0036-1583176.
PMID: 27231862 - 4
Pathology of Chronic Hypersensitivity Pneumonitis What Is It? What Are the Diagnostic Criteria? Why Do We Care?
Churg A, Bilawich A, Wright JL
Archives of pathology & laboratory medicine 2018; (142(1)):109-119 doi:10.5858/arpa.2017-0173-RA.
PMID: 28537805 - 5
High-Resolution CT Findings in Interstitial Lung Disease Associated with Connective Tissue Diseases: Differentiating Patterns for Clinical Practice-A Systematic Review with Meta-Analysis.
Drimus JC, Duma RC, Trăilă D, et al.
Journal of clinical medicine 2025; (14(17)) doi:10.3390/jcm14176164.
PMID: 40943925 - 6
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline.
Raghu G, Montesi SB, Silver RM, et al.
American journal of respiratory and critical care medicine 2024; (209(2)):137-152 doi:10.1164/rccm.202306-1113ST.
PMID: 37772985 - 7
Functional, radiological and survival outcomes in rheumatoid arthritis-associated interstitial lung disease: 24-month results from the BERTHA prospective cohort.
Kawano-Dourado L, Bonfiglioli K, Ribeiro ACM, et al.
BMJ open respiratory research 2026; (13(1)) doi:10.1136/bmjresp-2025-003973.
PMID: 41760357
This page about NSIP is for informational purposes only and does not constitute medical advice. Your pulmonologist and multidisciplinary care team should interpret your results and guide treatment for your situation.
Get notified when new evidence is published on Non-specific interstitial pneumonia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.